Pricing Log in Create free account

Inventiva S.A. Sponsored ADR (IVA) vs Latigo Biotherapeutics Inc (LTGO)

Inventiva S.A. Sponsored ADR and Latigo Biotherapeutics Inc are both Biotechnology companies. Inventiva S.A. Sponsored ADR and Latigo Biotherapeutics Inc are of similar size ($867.9M and $862.6M). Across the 3 metrics below, Latigo Biotherapeutics Inc leads on 2 and Inventiva S.A. Sponsored ADR on 1.

Valuation

Metric IVA LTGO Biotechnology median
P/E n/m — 10.60
P/S 7.43 n/m 9.40
P/B 2.13 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.54 n/m 9.02
Earnings yield (94.51%) — (32.88%)
Free cash flow yield (94.32%) 0.00% (23.13%)

Profitability

Metric IVA LTGO Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% — 0.00%
Net margin (750.28%) — 0.00%
Free cash flow margin 0.00% — 0.00%
Return on equity 0.00% — (51.96%)
Return on assets 0.00% — (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IVA LTGO Biotechnology median
Revenue growth (TTM) 547.89% — 6.76%
EPS growth (last fiscal year) 35.44% — 29.88%
Revenue growth, 5-year CAGR 8.33% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IVA LTGO Biotechnology median
Debt to equity 1.13 0.00 0.00
Current ratio 3.81 1.15 4.97
Net debt to EBITDA 0.29 — 1.01

Dividend

Metric IVA LTGO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IVA LTGO Biotechnology median
Market cap 867.93m 862.55m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack